NCT00828919 Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials Status COMPLETED Phase NA
NCT00827931 Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery Status COMPLETED Phase PHASE4
NCT00827502 Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections Status COMPLETED Phase N/A
NCT00827112 A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients Status COMPLETED Phase PHASE2
NCT00827034 A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects Status COMPLETED Phase PHASE1
NCT00826514 An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis Status COMPLETED Phase PHASE2
NCT00825084 A Phase 1 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF-01913539] In Japanese And Western Healthy Subjects Status COMPLETED Phase PHASE1
NCT00824850 Study Evaluating Prevnar Infant Long-term Immune Response Versus Prevnar Naive Cohort Status COMPLETED Phase PHASE2
NCT00824733 Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00824655 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Children Status COMPLETED Phase PHASE3
NCT00824590 A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function Status COMPLETED Phase PHASE1
NCT00824564 Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture Status COMPLETED Phase PHASE4
NCT00824421 A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1 Status COMPLETED Phase PHASE2
NCT00824369 A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1 Status TERMINATED Phase PHASE2
NCT00823979 A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 Status TERMINATED Phase PHASE2
NCT00823966 Safety And Efficacy Of Rescriptor In Patients For Human Immunodeficiency Virus (HIV) Patients Status COMPLETED Phase N/A
NCT00823745 Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects Status COMPLETED Phase PHASE1